Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study

被引:10
|
作者
Haass-Koffler, Carolina L. [1 ,2 ,3 ,4 ]
Long, Victoria M. [2 ]
Farokhnia, Mehdi [3 ,4 ]
Magill, Molly [2 ]
Kenna, George A. [1 ]
Swift, Robert M. [1 ,5 ]
Leggio, Lorenzo [2 ,3 ,4 ,6 ]
机构
[1] Brown Univ, Ctr Alcohol & Addict Studies, Dept Psychiat & Human Behav, 121 South Main St, Providence, RI 02912 USA
[2] Brown Univ, Ctr Alcohol & Addict Studies, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA
[3] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, Div Intramural Clin & Biol Res, Bethesda, MD 20892 USA
[4] NIDA, Intramural Res Program, NIH, Bethesda, MD 20892 USA
[5] Vet Affairs Med Ctr, Providence, RI USA
[6] NIDA, Medicat Dev Program, Intramural Res Program, NIH, Baltimore, MD USA
关键词
Alcohol use disorder; Aldosterone; Cortisol; Ghrelin; Craving; PITUITARY-ADRENAL AXIS; HPA-AXIS; SECRETAGOGUE-RECEPTOR; NATRIURETIC-PEPTIDE; CENTRAL NUCLEUS; STRESS; EXPRESSION; HYPOTHALAMUS; HORMONE; NEUROENDOCRINE;
D O I
10.1016/j.neuropharm.2019.107711
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence supports the role of appetite-regulating hormones, including ghrelin, in alcohol use disorder (AUD). Effects of ghrelin administration on cortisol and aldosterone, two hormones known to influence the development and maintenance of AUD, have been observed in ghrelin-exposed tissues or cells, as well as rodents and healthy volunteers, however whether these effects replicate in individuals with AUD is unknown. Here, we tested the hypothesis that intravenous administration of ghrelin leads to increase in endogenous serum cortisol and aldosterone concentrations in alcohol-dependent, heavy drinking individuals, and that these changes may predict ghrelin-induced alcohol craving. This was a double-blind, placebo-controlled human laboratory study in non-treatment-seeking, heavy-drinking, alcohol-dependent individuals randomized to receive either placebo, 1 mcg/kg or 3 mcg/kg of intravenous ghrelin. Then, participants underwent a cue-reactivity procedure in a bar-like setting, which included exposure to both neutral (juice) and alcohol cues. Repeated blood samples were collected and used to measure endogenous cortisol and aldosterone serum concentrations, in response to exogenous ghrelin administration. Furthermore, cortisol and aldosterone serum concentrations were used to develop a model to predict the effect of exogenous ghrelin administration on alcohol craving. Intravenous ghrelin administration increased endogenous cortisol and aldosterone serum concentrations. While the effects on cortisol were greater than those on aldosterone, only the ghrelin-induced changes in aldosterone serum concentrations predicted craving. These findings provide initial evidence of ghrelin effects on glucocorticoids and mineralocorticoids in individuals with AUD, thereby providing additional information on the potential mechanisms by which the ghrelin system may play a role in alcohol craving and seeking in AUD.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Intravenous Administration of Ghrelin Increases Blood Cortisol and Aldosterone Concentrations in Heavy-Drinking Alcohol-Dependent Individuals: Results From a Double-Blind Placebo-Controlled Human Laboratory Study
    Haass-Koffler, Carolina
    Long, Victoria
    Farokhnia, Mehdi
    Kenna, George
    Swift, Robert
    Leggio, Lorenzo
    [J]. NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S521 - S521
  • [2] INTRAVENOUS ADMINISTRATION OF GHRELIN INCREASES BLOOD CORTISOL AND ALDOSTERONE CONCENTRATIONS IN HEAVY-DRINKING ALCOHOL-DEPENDENT INDIVIDUALS
    Long, V. M.
    Farokhnia, M.
    Swift, R. M.
    Leggio, L.
    Haass-Koffler, C. L.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 : 224A - 224A
  • [3] Neuroendocrine Response to Exogenous Ghrelin Administration, Combined With Alcohol, in Heavy-Drinking Individuals: Findings From a Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study
    Farokhnia, Mehdi
    Abshire, Kelly M.
    Hammer, Aaron
    Deschaine, Sara L.
    Saravanakumar, Anitha
    Cobbina, Enoch
    You, Zhi-Bing
    Haass-Koffler, Carolina L.
    Lee, Mary R.
    Akhlaghi, Fatemeh
    Leggio, Lorenzo
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (06): : 464 - 476
  • [4] A Double-Blind, Placebo-Controlled Trial to Assess the Efficacy of Quetiapine Fumarate XR in Very Heavy-Drinking Alcohol-Dependent Patients
    Litten, Raye Z.
    Fertig, Joanne B.
    Falk, Daniel E.
    Ryan, Megan L.
    Mattson, Margaret E.
    Collins, Joseph F.
    Murtaugh, Cristin
    Ciraulo, Domenic
    Green, Alan I.
    Johnson, Bankole
    Pettinati, Helen
    Swift, Robert
    Afshar, Maryam
    Brunette, Mary F.
    Tiouririne, Nassima A. -D.
    Kampman, Kyle
    Stout, Robert
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 (03) : 406 - 416
  • [5] Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study
    M Farokhnia
    M L Schwandt
    M R Lee
    J W Bollinger
    L A Farinelli
    J P Amodio
    L Sewell
    T A Lionetti
    D E Spero
    L Leggio
    [J]. Translational Psychiatry, 2017, 7 : e1108 - e1108
  • [6] Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals
    M Farokhnia
    E N Grodin
    M R Lee
    E N Oot
    A N Blackburn
    B L Stangl
    M L Schwandt
    L A Farinelli
    R Momenan
    V A Ramchandani
    L Leggio
    [J]. Molecular Psychiatry, 2018, 23 : 2029 - 2038
  • [7] Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study
    Farokhnia, M.
    Schwandt, M. L.
    Lee, M. R.
    Bollinger, J. W.
    Farinelli, L. A.
    Amodio, J. P.
    Sewell, L.
    Lionetti, T. A.
    Spero, D. E.
    Leggio, L.
    [J]. TRANSLATIONAL PSYCHIATRY, 2017, 7 : e1108 - e1108
  • [8] Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals
    Farokhnia, M.
    Grodin, E. N.
    Lee, M. R.
    Oot, E. N.
    Blackburn, A. N.
    Stangl, B. L.
    Schwandt, M. L.
    Farinelli, L. A.
    Momenan, R.
    Ramchandani, V. A.
    Leggio, L.
    [J]. MOLECULAR PSYCHIATRY, 2018, 23 (10) : 2029 - 2038
  • [9] A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Levetiracetam Extended-Release in Very Heavy Drinking Alcohol-Dependent Patients
    Fertig, Joanne B.
    Ryan, Megan L.
    Falk, Daniel E.
    Litten, Raye Z.
    Mattson, Margaret E.
    Ransom, Janet
    Rickman, William J.
    Scott, Charles
    Ciraulo, Domenic
    Green, Alan I.
    Tiouririne, Nassima A.
    Johnson, Bankole
    Pettinati, Helen
    Strain, Eric C.
    Devine, Eric
    Brunette, Mary F.
    Kampman, Kyle
    Tompkins, David A.
    Stout, Robert
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 (08) : 1421 - 1430
  • [10] Effects of exogenous ghrelin administration and ghrelin receptor blockade, in combination with alcohol, on peripheral inflammatory markers in heavy-drinking individuals: Results from two human laboratory studies
    Farokhnia, Mehdi
    Portelli, Jeanelle
    Lee, Mary R.
    McDiarmid, Gray R.
    Munjal, Vikas
    Abshire, Kelly M.
    Battista, Jillian T.
    Browning, Brittney D.
    Deschaine, Sara L.
    Akhlaghi, Fatemeh
    Leggio, Lorenzo
    [J]. BRAIN RESEARCH, 2020, 1740